HLB Co., Ltd.
Research HLB Co., Ltd. (028300) on Bullrun: market cap KRW 4.78T. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker028300
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 4.78T
- Financial periodQ1 2026
- RevenueKRW 18.69B
- Net income-KRW 38.00B
- Free cash flow-KRW 18.36B
- Gross margin38.0%
Valuation Snapshot
latest market cap is KRW 4.78T.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | KRW 84.17B | -KRW 220.50B | -KRW 110.12B | 32.9% | n/a | KRW 40.98B | KRW 284.95B | KRW 418.46B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-28 | KRW 4.78T | n/a | n/a | n/a |
About HLB Co., Ltd.
HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, including alcohol swabs, sampling tools, etc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is HLB Co., Ltd.'s market cap?
HLB Co., Ltd.'s market capitalization is KRW 4.78T.
What does HLB Co., Ltd. do?
HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, including alcohol swabs, sampling tools, etc. The company is also involved in e-commerce, investment, and financing activities. Additionally, it develops biological drugs with MoA to infectious diseases.